封面
市場調查報告書
商品編碼
2084871

獸醫保健市場:依產品、動物種類及地區分類

Veterinary Healthcare Market, By Product (Therapeutics and Diagnostics), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, and Other Animals), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 257 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,醫療保健市場規模將達到467億美元,到2033年將達到853.68億美元。預計從2026年到2033年,其複合年成長率將達到9.0%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 467億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 9.00% 2033年市場規模預測: 853.68億美元

獸醫保健的重點是透過疾病診斷和治療來有效管理動物健康。它是一門醫學專科,致力於預防、診斷、管理和治療影響家畜和野生動物健康的疾病,並防止感染疾病疾病(通用和慢性病)在全球範圍內的傳播。早期發現是治療動物健康問題的關鍵。

市場動態

通用感染疾病的發病率和盛行率不斷上升,人們對獸醫學的關注度不斷提高,政府和動物福利組織的積極舉措,人們對獸醫護理的認知不斷提高,寵物飼養量的增加,以及新產品的推出,預計這些因素將成為推動全球獸醫市場成長的主要因素。

例如,2019年9月,阿布達比農業和食品安全總局(ADAFSA)啟動了2019-2020年度第十一屆年度疫苗宣傳活動,作為其在阿布達比酋長國對抗動物疾病工作的一部分。此次宣傳活動是ADAFSA大力支持酋長國畜牧養殖戶並推廣畜牧養殖最佳實踐舉措的一部分。

此外,2020 年 5 月,Felix Pharmaceuticals Pvt. Ltd. 宣布其「恩諾沙星調味片」已獲得美國食品藥物管理局(FDA) 的批准,用於治療細菌相關疾病。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數,對全球獸醫保健市場的主要參與者進行了概況介紹。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球獸醫保健市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
  • 相關人員可以透過利用全球獸醫保健市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 通用感染疾病盛行率和發生率增加
    • 獸醫保健服務/解決方案高成本
    • 人們越來越關注獸醫保健
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景

第4章 全球獸醫保健市場:依產品分類,2021-2033年

  • 治療
  • 診斷

第5章 全球獸醫保健市場:依動物類型分類,2021-2033年

  • 狗和貓
  • 反芻動物
  • 家禽
  • 其他動物

第6章 全球獸醫保健市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • Zoetis Inc.
  • Virbac SA
  • Vetoquinol SA
  • Phibro Animal Health
  • Merck & Co. Inc.
  • IDEXX Laboratories
  • Ceva SantE Animale
  • BioMerieux SA
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH

第8章

  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI5420

Veterinary Healthcare Market is estimated to be valued at USD 46,700 Mn in 2026 and is expected to reach USD 85,368 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 46,700 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.00% 2033 Value Projection: USD 85,368 Mn

Veterinary healthcare focuses on effective animal health management by diagnosing and treating diseases. It is a medical specialty concerned with the prevention, diagnosis, control, and treatment of diseases affecting the health of domestic and wild animals, as well as to prevent transmission of veterinary diseases (zoonotic and chronic) worldwide. Early detection is key when it comes to treating health problems in animals.

Market Dynamics

Increase in incidence/prevalence of zoonosis diseases, increase in focus on veterinary healthcare, favorable initiatives by governments and animal welfare associations, increase in awareness about veterinary healthcare, rise in adoption of pets, and introduction of novel products are major factors expected to drive growth of the global veterinary healthcare market.

For instance, in September 2019, Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) launched the 11th annual vaccination campaign for 2019-2020 against diseases affecting animals in the Emirate of Abu Dhabi. The campaign comes as part of ADAFSA's great support for livestock breeders in the emirate, to promote the best practices related to animal farming.

Moreover, in May 2020, Felix Pharmaceuticals Pvt. Ltd. announced that the U.S. Food and Drug Administration (FDA) approved its 'Enrofloxacin Flavored Tablets', for the treatment of diseases associated with bacteria.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global veterinary healthcare market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Zoetis Inc., Virbac SA, Vetoquinol SA, Phibro Animal Health, Merck & Co. Inc., IDEXX Laboratories, Ceva SantE Animale, BioMerieux SA, Elanco Animal Health Incorporated, and Boehringer Ingelheim International GmbH, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global veterinary healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary healthcare market.

Market Segmentation

  • By Product (Revenue, USD Mn, 2021 - 2033)
  • Therapeutics
  • Diagnostics
  • By Animal Type (Revenue, USD Mn, 2021 - 2033)
  • Dogs and Cats
  • Horses
  • Ruminants
  • Swine
  • Poultry
  • Other Animals
  • By Region (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
  • Zoetis Inc.
  • Virbac SA
  • Vetoquinol SA
  • Phibro Animal Health
  • Merck & Co. Inc.
  • IDEXX Laboratories
  • Ceva SantE Animale
  • BioMerieux SA
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Animal Type
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in prevalence/incidence of zoonosis diseases
    • High cost of veterinary healthcare services/solutions
    • Increase in focus on the veterinary healthcare
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Veterinary Healthcare Market, By Product, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Veterinary Healthcare Market, By Animal Type, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Dogs and Cats
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Horses
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Ruminants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Swine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Poultry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Other Animals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Veterinary Healthcare Market, By Region, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
    • Market Share Analysis, By Country, 2021-2033 (%)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
    • Market Share Analysis, By Country, 2021-2033 (%)
      • U.K.
      • Germany
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
    • Market Share Analysis, By Country, 2021-2033 (%)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
    • Market Share Analysis, By Country, 2021- 2033 (%)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
    • Market Share Analysis, By Country, 2021- 2033 (%)
      • GCC
      • Israel
      • Rest of the Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021-2033, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021-2033, (USD Mn)
    • Market Share Analysis, By Country, 2021- 2033 (%)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • IDEXX Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva SantE Animale
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

8. Section

  • Research Methodology
  • About us